Search Within

Isabelle C Riviere

  1. "Hematologic Malignancies Research"
  2. "Molecular Pharmacology and Chemistry Program Faculty"
  3. "Sloan Kettering Institute Postdocs"
  4. "American Society of Hematology"
Formats
  1. Meeting Abstract (11)
  2. Journal Article (1)
Groups
  1. Center for Hematologic Malignancies (12)
  2. Department of Medicine (12)
  3. GSK Faculty (12)
  4. Hematologic Malignancies Research (12)
  5. Hematologic Malignancies, Division of (12)
  6. Molecular Pharmacology and Chemistry Program Faculty (12)

More Groups

People
  1. Michel Sadelain (12)
  2. Sjoukje van der Stegen (5)
  3. Xiuyan Wang (5)
  4. Jae Park (4)
  5. Jorge Mansilla-Soto (3)
  6. Pieter Lindenbergh (3)

More People

Years
  1. 2023 (1)
  2. 2022 (3)
  3. 2020 (2)
  4. 2019 (1)
  5. 2018 (1)
  6. 2017 (2)

More Years

Publications
  1. Blood (12)
Publishers
  1. American Society of Hematology (12)

Results (12)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Long term follow-up after treatment with allogeneic off-the-shelf CAR T cell therapy for relapsed or refractory B-cell malignancies
    Meeting Abstract

    Shahid, S.; Flynn, G. C.; Mauguen, A.; Bieler, J.; Prockop, S. E.; Scaradavou, A.; Boelens, J. J.; Sauter, C. S.; Perales, M. A.; Giralt, S. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The development of allogeneic tips-derived TCR(-)CAR(+) CD8αβ T cells
    Meeting Abstract

    van der Stegen, S. J. C.; Petrovic, R. M.; Lindenbergh, P. L.; Diop, M. P.; Alexeeva, V.; Xie, H.; Clarke, R.; Valamehr, B.; Rivière, I.; Sadelain, M.
    Blood (2022)

    Fulltext@MSK | Save
  • A phase I study of CD19-targeted 19(T2)28z1XX CAR T cells in adult patients with relapsed or refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Park, J. H.; Palomba, M. L.; Rivière, I.; Sikder, D. S.; Senechal, B.; Wang, X.; Bermudez, V. P.; Cathcart, E. R.; Liotta, K.; Joseph, J.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Target densities in malignant and normal cells determine CAR T cell efficacy and off-target hematotoxicity
    Meeting Abstract

    Haubner, S.; Mansilla-Soto, J.; Nataraj, S.; Kogel, F.; Chang, Q.; De Stanchina, E.; Fraser, K.; Park, J. H.; Wang, X.; Rivière, I.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • NOTCH and CAR signaling control T cell lineage commitment from pluripotent stem cells
    Meeting Abstract

    Van der Stegen, S.; Lindenbergh, P.; Petrovic, R.; Whitlock, B.; Clarke, R.; Valamehr, B.; Riviere, I.; Sadelain, M.
    Blood (2020)

    Fulltext@MSK | Save
  • A phase I study of CD19-targeted 19(T2)28z1xx CAR T cells in adult patients with relapsed or refractory B-cell malignancies
    Meeting Abstract

    Park, J. H.; Riviere, I.; Sikder, D. S.; Bermudez, V. P.; Senechal, B.; Wang, X.; Auchincloss, T. H.; Diamonte, C.; Halton, E.; Palomba, M. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • FT819: Translation of off-the-shelf TCR-less TRAC-1XX CAR-T cells in support of first-of-kind phase I clinical trial
    Meeting Abstract

    Chang, C.; Van Der Stegen, S.; Mili, M.; Clarke, R.; Lai, Y. S.; Witty, A.; Lindenbergh, P.; Yang, B. H.; Husain, M.; Shaked, H.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Pluripotent cell-derived off-the-shelf TCR-less CAR-targeted cytotoxic T cell therapeutic for the allogeneic treatment of B cell malignancies
    Meeting Abstract

    Clarke, R.; Van Der Stegen, S.; Chang, C. W.; Husain, M.; Lai, Y. S.; Peralta, E.; Stokely, L.; Abujarour, R.; Dinella, J.; Lee, T.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Generation of clonal antigen specific CD8αβ(+) cytotoxic T lymphocytes from renewable pluripotent stem cells for off-the-shelf T cell therapeutics
    Meeting Abstract

    Van Der Stegen, S.; Clarke, R.; Mansilla-Soto, J.; Ortiz, E.; Chang, C. W.; Sasaki, J.; Lee, T.; Lan, W.; Shoemaker, D.; Riviere, I.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Safety and efficacy trial of escalation of plerixafor for mobilization of CD34+ hematopoietic progenitor cells (HPCs) for globin gene transfer in patients with sickle cell disease
    Meeting Abstract

    Boulad, F.; Shore, T. B.; Van Besien, K.; Guarneri, D.; Greenberg, J.; Minniti, C.; Wiener Fedus, S.; Perna, F.; Wang, X.; Riviere, I.; more...
    Blood (2017)

    Fulltext@MSK | Save